(Updated - October 23, 2019 4:06 PM EDT)(updated to correct rating)Oppenheimer analyst Jay Olson initiates coverage on Nektar Therapeutics (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE